NCT02641093 2024-08-29Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell CarcinomaUniversity of CincinnatiPhase 2 Active not recruiting96 enrolled 12 charts